Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension

Clinical and Experimental Hypertension : CHE
Arrigo F G CiceroClaudio Borghi

Abstract

Our aim was to evaluate the predictors of Isoleucine-Proline-Proline/Valine-Proline-Proline (IPP-VPP) lactotripeptides (LTPs) antihypertensive effect in the context of a short-term large double-blind randomized clinical trial involving 164 pharmacologically untreated subjects in primary prevention for cardiovascular disease. When compared with the baseline, office systolic blood pressure (SBP) (-3.42 mm Hg, P < .001) and diastolic blood pressure (DBP) (-2.35 mm Hg, P < .001) significantly decreased, in the LTP-treated patients only. No significant change in predictors during the study of ambulatory blood pressure measurement (ABPM) parameters was observed. A short-term supplementation with LTPs significantly improves the office SBP and DBP, especially in male subjects. The main predictor of LTP antihypertensive effect was the baseline BP.

References

Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Apr 12, 2005·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Gordon T McInnes
Sep 1, 2007·Journal of Hypertension·Giuseppe ManciaUNKNOWN ESH-ESC Task Force on the Management of Arterial Hypertension
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
Dec 9, 2008·The British Journal of Nutrition·Esther Boelsma, Joris Kloek
Dec 10, 2008·The American Journal of Clinical Nutrition·Kim van der ZanderPeter W de Leeuw
Dec 25, 2008·The American Journal of Clinical Nutrition·Linda A J van MierloRichard Draijer
Jul 9, 2009·The Journal of Clinical Hypertension·Lawrence J AppelMichael A Weber
Jul 16, 2009·Current Vascular Pharmacology·Arrigo F G CiceroClaudio Borghi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.